Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 3.48449 | 57 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 3.3947 | 56 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 3.39843 | 56 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 3.29855 | 54 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 3.31283 | 55 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 3.49089 | 56 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 3.53495 | 57 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 3.37544 | 55 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 3.32829 | 54 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 3.37224 | 55 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 3.38831 | 56 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 3.32018 | 55 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 3.44674 | 57 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 3.38582 | 55 |